Frontiers in Oncology | Thoracic Oncology

Brief Research Report

Published on 21 Mar 2023

Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis

in Thoracic Oncology

Samuel A. Kareff
Kunal Gawri
Khadeja Khan
Deukwoo Kwon
Estelamari Rodriguez
Gilberto de Lima Lopes
Richa Dawar

Frontiers in Oncology

doi 10.3389/fonc.2023.1012783

5,990 views
3 citations

Original Research

Published on 20 Mar 2023

CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma

in Thoracic Oncology

Jingting Wang
Feiyang Zhong
Feng Xiao
Xinyang Dong
Yun Long
Tian Gan
Ting Li
Meiyan Liao

Frontiers in Oncology

doi 10.3389/fonc.2023.1157891

3,721 views
6 citations

Original Research

Published on 20 Mar 2023

New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis

in Thoracic Oncology

Li-Hua Zhu
Xing-Wen Fan
Lu Sun
Ting-ting Ni
Ya-qi Li
Chao-Yang Wu
Kai-Liang Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1093084

2,522 views
3 citations

Original Research

Published on 20 Mar 2023

Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer

in Thoracic Oncology

Yang Wang
Shilei Qin
Yuepei Liang
Ling Yan
Min Zheng
Yanwu Zeng
Leilei Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1119575

2,464 views
3 citations

Original Research

Published on 17 Mar 2023

Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma

in Thoracic Oncology

Zhe-Rong Zheng
Hsiu-Ying Ku
Kun-Chieh Chen
Chun-Ju Chiang
Chih-Liang Wang
Chih-Yi Chen
Chun-Ming Tsai
Ming-Shyan Huang
Chong-Jen Yu
Jin-Shing Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1063695

3,114 views
4 citations

Case Report

Published on 16 Mar 2023

Case report: The stroma-rich variant of Castleman’s disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node

in Thoracic Oncology

Xiaoxin Shi
Mengying Liao
Xiaomin Yin
Yaoli Chen
Chuqiang Huang
Weihua Yin
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1008587

2,888 views
3 citations

Systematic Review

Published on 16 Mar 2023

Comparison of the second-line treatments for patients with small cell lung cancer sensitive to previous platinum-based chemotherapy: A systematic review and Bayesian network analysis

in Thoracic Oncology

Hekai Shi
Nuojin Guo
Zeming Zhao
Ligang Liu
Tianyi Ni
Jinye Zhang
Yingjie Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1154685

5,293 views
4 citations

Case Report

Published on 16 Mar 2023

Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report

in Thoracic Oncology

Zhifeng Ye
Junhua Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1082115

3,452 views
5 citations

Original Research

Published on 15 Mar 2023

Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region

in Thoracic Oncology

Yunjiao Wu
Jing Yang
Xinyi Qiao
Yingjie Li
Rui Zhao
Tie Lin
Xiaoli Li
Meng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1041140

2,942 views
8 citations

Editorial

Published on 14 Mar 2023

Editorial: Prognostic factors in non-small cell lung cancer

in Thoracic Oncology

Mohamed Rahouma
Massimo Baudo
Jun Zhang
Luciano Mutti

Frontiers in Oncology

doi 10.3389/fonc.2023.1174625

1,968 views
1 citation

Original Research

Published on 14 Mar 2023

Cost-effectiveness evaluation based on two models of first-line atezolizumab monotherapy and chemotherapy for advanced non-small cell lung cancer with high-PDL1 expression

in Thoracic Oncology

Chuan Zhang
Yue Liu
Jing Tan
Panwen Tian
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1093469

4,662 views
4 citations

Case Report

Published on 14 Mar 2023

Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report

in Thoracic Oncology

Aakriti Arora
Jacob Zaemes
Metin Ozdemirli
Chul Kim

Frontiers in Oncology

doi 10.3389/fonc.2023.1134151

3,455 views
11 citations

Original Research

Published on 13 Mar 2023

Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC

in Thoracic Oncology

Long Jin
Qifan Zhao
Shenbo Fu
Fei Cao
Bin Hou
Jia Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1092478

5,730 views
13 citations

Original Research

Published on 13 Mar 2023

Adjuvant EGFR-TKI therapy in resected EGFR-mutation positive non-small cell lung cancer: A real-world study

in Thoracic Oncology

Jun-Feng Liu
Xu-Sheng Sun
Jin-Huan Yin
Xi-E Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1132854

3,937 views
5 citations

Brief Research Report

Published on 13 Mar 2023

Heterogeneity of tumour mutational burden in metastatic NSCLC demonstrated by endobronchial ultrasound sampling

in Thoracic Oncology

Tracy L. Leong
Christian Aloe
Savreet Aujla
Hao Wang
Velimir Gayevskiy
Marie-Liesse Asselin-Labat
Lesley-Ann Gray
Daniel Steinfort
Steven Bozinovski

Frontiers in Oncology

doi 10.3389/fonc.2023.1150349

2,346 views
8 citations

Case Report

Published on 10 Mar 2023

Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report

in Thoracic Oncology

Hongming Wang
Zhijun Wu
Yangfeng Du
Tao Wu
Wei Tian
Wen Dong
Juan Cai
Jiang Zheng
Yan Zhang
Shiyan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1145021

3,583 views
3 citations

Mini Review

Published on 09 Mar 2023

The use of nanoparticles for targeted drug delivery in non-small cell lung cancer

in Thoracic Oncology

Jessica E. Holder
Christopher Ferguson
Elisabete Oliveira
Carlos Lodeiro
Carol M. Trim
Lee J. Byrne
Emilia Bertolo
Cornelia M. Wilson

Frontiers in Oncology

doi 10.3389/fonc.2023.1154318

9,233 views
35 citations

Study Protocol

Published on 09 Mar 2023

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

in Thoracic Oncology

Marinda Meertens
M. Benthe Muntinghe-Wagenaar
Barend J. Sikkema
Marta Lopez-Yurda
Valesca P. Retèl
Marthe S. Paats
Rob Ter Heine
Ed Schuuring
Wim Timens
Daan J. Touw

Frontiers in Oncology

doi 10.3389/fonc.2023.1136221

10,626 views
10 citations

Original Research

Published on 09 Mar 2023

Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

in Thoracic Oncology

Chien-Hung Gow
Min-Shu Hsieh
Yi-Lin Chen
Yi-Nan Liu
Shang-Gin Wu
Jin-Yuan Shih

Frontiers in Oncology

doi 10.3389/fonc.2023.1113696

5,867 views
8 citations

Review

Published on 09 Mar 2023

Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer

in Thoracic Oncology

Yu-Chen Yang
Can-Jun Zhao
Zhao-Feng Jin
Jin Zheng
Li-Tian Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1120828

6,442 views
10 citations

Review

Published on 08 Mar 2023

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer

in Thoracic Oncology

Remziye Zaim
W. Ken Redekop
Carin A. Uyl-de Groot

Frontiers in Oncology

doi 10.3389/fonc.2023.1027659

2,302 views
1 citation

Brief Research Report

Published on 08 Mar 2023

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer

in Thoracic Oncology

Ziran Zhao
Yibo Gao
Fengwei Tan
Qi Xue
Shugeng Gao
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2023.1018288

3,238 views

Review

Published on 07 Mar 2023

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

in Thoracic Oncology

Qiuyuan Hu
Ke Li
Conghui Yang
Yue Wang
Rong Huang
Mingqiu Gu
Yuqiang Xiao
Yunchao Huang
Long Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1133164

7,535 views
27 citations

Original Research

Published on 07 Mar 2023

A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

in Thoracic Oncology

Chengyu Chen
Qun Geng
Gesheng Song
Qian Zhang
Youruo Wang
Dongfeng Sun
Qingshi Zeng
Zhengjun Dai
Gongchao Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1066360

2,872 views
12 citations